| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2015-04-23 | SkQ1 | dry eye syndrome |
2 | Mitotech (Luxembourg) | Ophtalmological diseases |
| 2015-04-23 | sofosbuvir, velpatasvir (GS-5816) and GS-9857 (voxilaprevir) | hepatitis C | 1,2 | Gilead Sciences (USA - CA) | Infectious diseases |
| 2015-04-22 | marizomib and bevacizumab (Avastin®) | malignant glioma | 1 | Triphase Accelerator (Canada - USA - CA) | Cancer - Oncology |
| 2015-04-22 | GEN-004 | prevention of infection by all serotypes of pneumococcus |
2 | Genocea Biosciences (USA - MA) | Infectious diseases |
| 2015-04-22 | cancer immunotherapy | BioNTech (Germany) | Cancer - Oncology | ||
| 2015-04-22 | PL37 | diabetic neuropathy |
2 | Pharmaleads (France) | CNS diseases - Metaboic diseases |
| 2015-04-22 | tarloxotinib (TH-4000) | non-small cell lung cancer (NSCLC) | preclinical | Threshold Pharmaceuticals (USA - CA) | Cancer - Oncology |
| 2015-04-22 | Epidiolex® (cannabidiol (2-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) | Lennox-Gastaut syndrome | GW Pharmaceuticals (UK) | Rare diseases - CNS diseases - Neurological diseases | |
| 2015-04-21 | TG4010 and TG3003 | preclinical | Transgene (France) | Cancer - Oncology | |
| 2015-04-21 | autologous CD34+ cells transduced with a lentiviral vector containing the human Wiskott-Aldrich syndrome gene | Wiskott Aldrich syndrome |
1-2 | Genethon (France) AFM-Telethon (France) UCL Institute of Child Health (UK) Great Ormond Street Hospital (UK) AP-HP (France) Inserm (France) Children's Hospital Boston (USA) | Rare diseases |
| 2015-04-21 | 4Kscore® Test | prostate cancer | Opko Health (USA - Fl) | Cancer - Oncology - Diagnostic | |
| 2015-04-21 | Vaxfectin® | congenital cytomegalovirus infection |
preclinical | Vical (USA - CA) | Infectious diseases |
| 2015-04-21 | GZ/SAR402671 | Fabry disease |
2a | Genzyme (USA - MA), a Sanofi company (France) | Rare diseases - Genetic diseases |
| 2015-04-21 | JCAR017 (CD19 specific CAR T cells also expressing an EGFRt) | acute lymphoblastic leukemia | 1-2 | Seattle Children's Hospital (USA - WN) Juno Therapeutics (USA - WA) | Cancer - Oncology |
| 2015-04-21 | INO-1800, alone or in combination with INO-9112 | hepatitis B |
1 | Inovio Pharmaceuticals (USA - PA) Roche (Switzerland) | Infectious diseases |
| 2015-04-21 | brigatinib (AP26113) | preclinical | Ariad Pharmaceuticals (USA - MA) | Cancer - Oncology | |
| 2015-04-21 | NuQ® assays | precancerous colorectal polyps |
VolitionRx (Singapore) Hvidovre Hospital (Denmark) | Diagnostic - Cancer - Oncology | |
| 2015-04-20 | ProCervix® | treatment of adult women already infected with human papillomavirus (HPV) genotype 16 or 18 |
preclinical | Genticel (France) | Cancer - Oncology - Infectious diseases |
| 2015-04-20 | AM-101 | acute peripheral tinnitus | 2 | Auris Medical (Switzerland) | Otorhinolaryngology |
| 2015-04-20 | Mission Therapeutics (UK) |
